PD 128483
Latest Information Update: 11 Jan 1999
Price :
$50 *
At a glance
- Originator Pfizer
- Class Aminoquinolines; Antipsychotics; Small molecules; Thiazoles
- Mechanism of Action Dopamine receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 11 Jan 1999 No-Development-Reported for Cocaine abuse in USA (Unknown route)
- 07 Sep 1998 No-Development-Reported for Psychotic disorders in USA (Unknown route)
- 25 Aug 1995 Investigation in Cocaine abuse in USA (Unknown route)